rifamycin SV

(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate

HJYYPODYNSCCOU-ODRIEIDWSA-N CHEBI:29673 0 Reactome links 4 studies
4 Observed studies
4 Observed diff profiles
0 Reactome pathways

Metabolite details

Identifier
HJYYPODYNSCCOU-ODRIEIDWSA-N
IUPAC name
(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate
Preferred name
rifamycin SV
INN name
rifamycine
Synonym
Rifocin
ChEBI
CHEBI:29673

Reactome pathways

  • No Reactome pathways listed for this metabolite.

Observed in studies

Observed in differential profiles